XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segment Information - Schedule of Business Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 28, 2023
Jul. 29, 2023
Oct. 29, 2022
Oct. 28, 2023
Oct. 29, 2022
Jan. 28, 2023
Segment Reporting Information [Line Items]            
Net sales $ 579,315 [1]   $ 603,788 [2] $ 1,585,674 [3] $ 1,659,868 [4]  
Segment operating income (loss) 10,951     (21,738) 43,247  
Goodwill impairment 0   0 28,453 [5] 0  
Asset impairments and other 99 [6]   0 581 [7] (154) [8]  
Operating income (loss) 10,852   26,073 (50,772) 43,401  
Other components of net periodic benefit cost 148   50 388 198  
Interest expense, net 2,207   906 6,241 1,608  
Earnings (loss) from continuing operations before income taxes 8,497   25,117 (57,401) 41,595  
Total assets 1,492,931 [9]   1,536,993 [10] 1,492,931 [9] 1,536,993 [10] $ 1,456,426
Depreciation and amortization 12,330   10,672 35,449 31,901  
Capital expenditures 14,440   10,840 49,738 39,845  
Journeys Group            
Segment Reporting Information [Line Items]            
Net sales 349,367 [1]   380,619 [2] 908,832 [3] 1,016,396 [4]  
Schuh Group            
Segment Reporting Information [Line Items]            
Net sales 118,129 [1]   104,809 [2] 334,033 [3] 294,486 [4]  
Johnston & Murphy Group            
Segment Reporting Information [Line Items]            
Net sales 81,411 [1]   79,614 [2] 241,823 [3] 225,448 [4]  
Genesco Brands Group            
Segment Reporting Information [Line Items]            
Net sales 30,408 [1]   38,746 [2] 100,986 [3] 123,538 [4]  
Goodwill impairment   $ 28,500   28,500    
Operating Segments            
Segment Reporting Information [Line Items]            
Net sales 581,817   605,703 1,588,929 1,662,772  
Operating Segments | Journeys Group            
Segment Reporting Information [Line Items]            
Net sales 349,367   380,619 908,832 1,016,396  
Segment operating income (loss) 11,975     (21,265) 51,235  
Goodwill impairment [5]       0    
Asset impairments and other 0 [6]     0 [7] 0 [8]  
Operating income (loss) 11,975   27,083 (21,265) 51,235  
Other components of net periodic benefit cost 0   0 0 0  
Interest expense, net 0   0 0 0  
Earnings (loss) from continuing operations before income taxes 11,975   27,083 (21,265) 51,235  
Total assets 798,968 [9]   841,021 [10] 798,968 [9] 841,021 [10]  
Depreciation and amortization 8,078   6,849 23,235 21,060  
Capital expenditures 8,235   4,638 32,447 15,539  
Operating Segments | Schuh Group            
Segment Reporting Information [Line Items]            
Net sales 118,129   104,809 334,033 294,486  
Segment operating income (loss) 5,484     12,110 5,260  
Goodwill impairment [5]       0    
Asset impairments and other 0 [6]     0 [7] 0 [8]  
Operating income (loss) 5,484   5,912 12,110 5,260  
Other components of net periodic benefit cost 0   0 0 0  
Interest expense, net 0   0 0 0  
Earnings (loss) from continuing operations before income taxes 5,484   5,912 12,110 5,260  
Total assets 213,036 [9]   206,996 [10] 213,036 [9] 206,996 [10]  
Depreciation and amortization 1,566   1,485 4,751 4,607  
Capital expenditures 3,380   2,405 9,376 6,278  
Operating Segments | Johnston & Murphy Group            
Segment Reporting Information [Line Items]            
Net sales 81,414   79,614 241,832 225,448  
Segment operating income (loss) 2,706     10,178 7,256  
Goodwill impairment [5]       0    
Asset impairments and other 0 [6]     0 [7] 0 [8]  
Operating income (loss) 2,706   3,494 10,178 7,256  
Other components of net periodic benefit cost 0   0 0 0  
Interest expense, net 0   0 0 0  
Earnings (loss) from continuing operations before income taxes 2,706   3,494 10,178 7,256  
Total assets 185,179 [9]   193,039 [10] 185,179 [9] 193,039 [10]  
Depreciation and amortization 1,365   1,092 3,622 3,271  
Capital expenditures 1,975   1,719 5,277 5,528  
Operating Segments | Genesco Brands Group            
Segment Reporting Information [Line Items]            
Net sales 32,907   40,661 104,232 126,442  
Segment operating income (loss) (1,560)     259 2,551  
Goodwill impairment [5]       0    
Asset impairments and other 0 [6]     0 [7] 0 [8]  
Operating income (loss) (1,560)   (1,927) 259 2,551  
Other components of net periodic benefit cost 0   0 0 0  
Interest expense, net 0   0 0 0  
Earnings (loss) from continuing operations before income taxes (1,560)   (1,927) 259 2,551  
Total assets 52,170 [9]   72,586 [10] 52,170 [9] 72,586 [10]  
Depreciation and amortization 265   214 669 692  
Capital expenditures 710   370 1,788 1,033  
Corporate & Other            
Segment Reporting Information [Line Items]            
Net sales 0 [1]   0 [2] 0 [3] 0 [4]  
Segment operating income (loss) (7,654)     (23,020) (23,055)  
Goodwill impairment [5]       28,453    
Asset impairments and other 99 [6]     581 [7] (154) [8]  
Operating income (loss) (7,753)   (8,489) (52,054) (22,901)  
Other components of net periodic benefit cost 148   50 388 198  
Interest expense, net 2,207   906 6,241 1,608  
Earnings (loss) from continuing operations before income taxes (10,108)   (9,445) (58,683) (24,707)  
Total assets 243,578 [9]   223,351 [10] 243,578 [9] 223,351 [10]  
Depreciation and amortization 1,056   1,032 3,172 2,271  
Capital expenditures 140   1,708 850 11,467  
Intercompany Sales            
Segment Reporting Information [Line Items]            
Net sales (2,502)   (1,915) (3,255) (2,904)  
Intercompany Sales | Journeys Group            
Segment Reporting Information [Line Items]            
Net sales 0   0 0 0  
Intercompany Sales | Schuh Group            
Segment Reporting Information [Line Items]            
Net sales 0   0 0 0  
Intercompany Sales | Johnston & Murphy Group            
Segment Reporting Information [Line Items]            
Net sales (3)   0 (9) 0  
Intercompany Sales | Genesco Brands Group            
Segment Reporting Information [Line Items]            
Net sales $ (2,499)   $ (1,915) $ (3,246) $ (2,904)  
[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the third quarter of Fiscal 2024.
[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 83% and 17%, respectively, of our net sales for the third quarter of Fiscal 2023.
[3]

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales in the first nine months of Fiscal 2024.

[4]

(1) Net sales in North America and in the U.K., which includes the ROI, accounted for 82% and 18%, respectively, of our net sales for the first nine months of Fiscal 2023.

[5]

(2) Goodwill impairment of $28.5 million is related to Genesco Brands Group.

[6] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group.
[7]

(3) Asset impairments and other includes a $0.6 million charge for asset impairments in Journeys Group.

[8]

(2) Asset impairments and other includes a $0.5 million charge for asset impairments, which includes $0.2 million in Journeys Group, $0.2 million in Schuh Group and $0.1 million in Genesco Brands Group, partially offset by a $0.7 million gain on the termination of the pension plan.

[9] Of our $704.5 million of long-lived assets, $87.9 million and $12.9 million relate to long-lived assets in the U.K. and Canada, respectively.
[10]

(2) Of our $704.6 million of long-lived assets, $89.3 million and $18.5 million relate to long-lived assets in the U.K. and Canada, respectively.